Page 106 - 22-0424
P. 106
The International Journal of the Royal Society of Thailand
Volume XI - 2019
problems, such as ending tuberculosis, early detection of cancers, diagnosis of
rare disease patients. To realize the benefit of genomic medicine for Thailand,
it is imperative to implement genomic medicine with good clinical and information
technology practice.
References
Collins FS and Varmus H. A new initiative on precision medicine. N. Engl. J. Med.
2015;372,793–795. doi:10.1056/NEJMp1500523.
Dzau VJ, Ginsburg GS, Van Nuys K, Agus D, Goldman D. Aligning incentives to
fulfil the promise of personalised medicine. Lancet 2015;385,2118–2119.
doi:10.1016/ S0140-6736(15)60722-X.
Eurordis. What is a rare disease? 2019. https://www.eurordis.org/content/
what-rare-disease.
Giardiello F, Allen J, Axilbund J, Boland R, Burke C, Burt R et al. Guidelines on
genetic evaluation and management of lynch syndrome: A consensus
statement by the US multi-society task force on colorectal cancer.
Gastroenterology. 2014;147,502–526. doi:10.1053/j.gastro.2014.04.001.
Grabowski MK, Herbeck J, Poon A. Genetic Cluster Analysis for HIV Prevention.
Curr HIV/AIDS Rep. 2018;15(2):182–189. doi:10.1007/s11904-018-0384-1.
Huang K, Mashl R, Wu Y, Ritter D, Wang J, Oh C et al. Pathogenic germline variants
in 10,389 adult cancers. Cell. 2018;173(2):355–370. doi:10.1016/j.cell.
2018.03.039.
Hung SL, Chung W, Liou L, Chu C, Lin M, Huang H, et al. HLA-B*5801 allele as
a genetic marker for severe cutaneous adverse reactions caused by
allopurinol. Proc Natl Acad Sci. 2005;102(11):4134–4139. doi:10.1073/pnas.
0409500102.
King MC, Marks JH, Mandell JB. Breast and Ovarian Cancer Risks Due to
Inherited Mutations in BRCA1 and BRCA2. Science. 2003;302,643–646.
doi:10.1126/science.1088759.
Locharernkul C, Loplumlert J, Limotai C, Korkij W, Desudchit T, Tongkobpetch
S, et al. Carbamazepine and phenytoin induced Stevens-Johnson syndrome
is associated with HLA-B*1502 allele in Thai population. Epilepsia. 2008;
49(12):2087–2091. doi:10.1111/j.1528-1167.2008.01719.x.
100 Precision Medicine: Preventive aspect
11/7/2565 BE 13:30
_22-0424(089-102)9.indd 100 11/7/2565 BE 13:30
_22-0424(089-102)9.indd 100